News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
04-Feb-2008 - AVONTEC GmbH announced that the US Patent and Trademark office has granted a patent that protects its lead drug candidate AVT-01 decoy oligonucleotide (AVT-01 decoy ODN). AVONTEC is developing AVT-01 decoy ODN for the treatment of chronic inflammatory diseases and is currently testing this drug ...
04-Feb-2008 - Scientists from deCODE genetics report the discovery of two common, single-letter variants in the sequence of the human genome (SNPs) that regulate one of the principle motors of evolution. Versions of the two SNPs, located on chromosome 4p16, have a genome-wide impact on the rate of ...
04-Feb-2008 - Indivumed GmbH announced the appointment of Harald R Eistetter, PhD, as Managing Director and to the newly created position of Chief Business Officer. Dr Eistetter, who has more than two decades of leadership experience in the pharmaceutical and biotech industry, will be responsible in ...
01-Feb-2008 - Stem Cell Sciences plc has entered an agreement with the Myelin Repair Foundation (MRF) for the development of techniques that will lead to scalable and sustainable sources of uniform human brain cells for research, target validation and drug discovery assays. Being able to utilise human brain ...
01-Feb-2008 - Sequenom, Inc. announced that the Company will conduct a multi-center fetal Rhesus D (RhD) genotype study at centers affiliated with the North American Fetal Therapy Network (NAFTNet), a nonprofit research network with expertise in the care for pregnancies at high risk of complex fetal disorders. ...
01-Feb-2008 - Thermo Fisher Scientific Inc. announced a collaborative partnership with the newly opened Vascular Proteomics Group at the James Black Center, King's College London, headed by Dr. Manuel Mayr. Started in June 2007, the facility is equipped with the combination of a Thermo Scientific LTQ Orbitrap ...
Naama Barkai awarded 2008 FEBS/EMBO Women in Science Award
01-Feb-2008 - The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announced Naama Barkai of the Weizman Institute of Science in Rehovot, Israel as the first-ever winner of the FEBS/EMBO Women in Science Award. Naama Barkai receives the 2008 award for ...
01-Feb-2008 - BTG plc announced that BGC20-1531, a potential treatment for migraine headaches, has commenced clinical development. Dosing has begun in a randomised, double-blind, placebo controlled phase I study, which will assess the safety, tolerability and pharmacokinetic profile of single rising doses of ...
31-Jan-2008 - For most people, the name "E. coli" is synonymous with food poisoning and product recalls, but a professor in Texas A&M University's chemical engineering department envisions the bacteria as a future source of energy, helping to power our cars, homes and more. By genetically modifying the ...
31-Jan-2008 - University of Alberta researchers in Edmonton, Canada, have developed a portable unit for genetic testing about the size of a shoebox, which has the same capability as a lab full of expensive equipment. The device - along with other, even smaller units the team is now in the process of developing ...
© 1997-2024 LUMITOS AG, All rights reserved